Multimodal Analgesia Effect on Post Surgical Patient

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

Patients undergoing Bariatric Surgery at the University of California Davis Medical Center will be divided into two groups, one receiving Standard of Care pain control medications vs the second group which will receive non-narcotic pain medications with rescue pain medications available if needed

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, Davis
• Treatments: Acetaminophen; Bupivacaine; Butylscopolammonium Bromide; Cyclobenzaprine; Gabapentin; Hydrocodone; Hydromorphone; Oxycodone; Scopolamine

Criteria

Inclusion Criteria:

• Women who undergo index weight loss procedures at UC Davis Medical Center

• Women with a BMI =>30

• Age from 35-65

• American Society of Anesthesiology (ASA) score of 3 or less

• No previous history of prior abdominal/foregut surgery

Exclusion Criteria:

• Not having an index weight los surgery for obesity

• Do not meet the NIH Standards for weight loss surgery

• Additional planned or unplanned procedures during the index surgical procedure such as Cholecystectomy or extensive lysis of adhesions (>30 minutes)

• BMI < 30

• Men

• Women considering or currently planning on gender altering/modification

• ASA score of 4 or higher

• Patients less than 35 years of age or older than 65 years of age at the time of surgical consent

• A history of open abdominal surgery including umbilical, ventral, or splengalic hernia repair with or without mesh implantation, transplant or vascular surgery or any foregut procedures including hiatal hernia repair or anti-reflux surgery

• Arthritis, Fibromyalgia, chronic pain syndrome

• Other conditions requiring daily use of oral pain medications

• Prisoners

• Allergy to Gabapentin